Future of Medical Radioisotope Supply Discussed at NEA Workshop
The Nuclear Energy Agency (NEA) recently convened a workshop to explore advancements and challenges in the supply of medical radioisotopes.
Biotech Update: RevMed, Roche, and Kyverna CAR-T Therapy Insights
Stay informed with the latest developments in the biotech sector, featuring updates on RevMed, Roche, and Kyverna's CAR-T therapy.
Exploring the Complex Narratives Behind Pharmaceutical Innovations
Thomas Goetz emphasizes that each drug represents a broader narrative involving health, medicine, society, and economics.
Roche Pursues Regulatory Approval for MS Drug Despite Ongoing Safety Concerns
Roche is advancing its experimental multiple sclerosis drug to regulators following successful trials, though significant safety concerns persist.
Purdue Pharma's $225 Million Forfeiture Paves the Way for Settlement Finalization
A judge is anticipated to impose a $225 million forfeiture on Purdue Pharma, the maker of OxyContin, facilitating the completion of its settlement with the Justice Department.
Purdue Pharma to Forfeit $225 Million in Settlement with Justice Department
A U.S. judge is anticipated to order Purdue Pharma to forfeit $225 million, marking a significant step in ongoing legal proceedings.
Understanding the Ongoing Battle Over Drug Price Transparency
A closer look at the ongoing disputes surrounding drug price transparency and the role of pharmacy benefit managers (PBMs) in this contentious issue.
Trump Advocates for Psychedelic Treatments and Weight-Loss Drug Developments
In recent pharmaceutical news, Trump has shown support for psychedelic treatment options while discussions continue regarding the future of weight-loss drugs.
Nektar Therapeutics Drug Shows Potential for Alopecia Treatment
Recent findings suggest that prolonged use of a drug from Nektar Therapeutics may encourage hair growth in individuals suffering from alopecia.
Pharmacy Benefit Managers Challenge Trump's Drug Price Transparency Proposal
Pharmacy benefit managers (PBMs) are opposing a significant proposal aimed at increasing transparency in drug pricing, claiming it may be illegal.
Insights from AACR 2026: Progress in KRAS Drug Development by Revolution Medicines
The American Association of Cancer Researchers' annual meeting showcases significant advancements in the development of KRAS-targeting therapies, particularly by Revolution Medicines.
Zai Lab and Amgen Collaborate on Lung Cancer Therapy Evaluation
Zai Lab and Amgen have announced a partnership to evaluate a new approach to lung cancer treatment, marking a significant step in cancer research.
Ultragenyx's Gene Therapy for Sanfilippo Syndrome Receives FDA Acceptance
The FDA has accepted Ultragenyx's Biologics License Application for its gene therapy UX111, aimed at treating Sanfilippo Syndrome.
Revolution Medicines' Daraxonrasib Shows Promise in Pancreatic Cancer Treatment
The pancreatic cancer drug Daraxonrasib from Revolution Medicines is reportedly achieving remarkable results, with some patients experiencing doubled survival times.
Understanding Vaccine Trust: A Closer Look at Recent Polls
Recent headlines may suggest a growing skepticism towards vaccines among Americans, but a new poll indicates that this perception may not reflect reality.
Trump Budget’s ‘America First’ Drug Policy Proposals
Strategic angle: New ideas to bring drug manufacturing to the U.S. are included in Trump's 2027 budget proposal.
FDA Seeks to Strengthen Domestic Drug Manufacturing Through New Proposals
In a move to enhance local drug production, the FDA has proposed new policies as part of the president's budget, aiming to support domestic drug development.
How an eye physician who translated classical Greek medicine into Arabic helped form Western medical thought
Strategic angle: A medieval ophthalmologist who translated Greek works by Galen, Hippocrates, and Plato into Arabic played a pivotal role in shaping Western medical scholarship, according to a study published in the journal Cogent Arts a
A nanoparticle therapy to treat lung cancer and associated muscle wasting at the same time
Strategic angle: Researchers at Oregon State University have developed a technique for simultaneously treating lung cancer and a serious muscle-wasting condition that often accompanies it.
Dual-drug nanotherapy crosses blood–brain barrier, improving survival in preclinical glioblastoma models
Strategic angle: Mayo Clinic researchers developed an experimental nanotherapy that delivers two cancer drugs directly to brain tumors, extending survival in preclinical models.